As a secondary study objective, we also compared the performance of CRB-65 (a non-serum-based biomarker) against established serum inflammatory biomarkers of infection (C-reactive protein (CRP) and white cell count (WCC)) for prognosticating COVID-19 patients. The gene discussed is CRP; the disease is infection.